Evaluation of the Adjuvant Activity of Herniaria glabra Saponin-Based Nanoadjuvants

Molecules, 2026

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.3390/molecules31193523
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

The increasing use of subunit and recombinant vaccines has created a demand for safe and effective adjuvants capable of enhancing immune responses. Here, we investigated a saponin-rich fraction isolated from Herniaria glabra as a source of novel nanoparticulate vaccine adjuvants. The saponins spontaneously self-assembled with lipid components to form stable nanocomplexes with favorable physicochemical characteristics. In a murine immunization model using viral glycoprotein antigens, these nanocomplexes significantly enhanced antigen-specific immune responses, increasing antibody titers by 8- to 16-fold compared with antigen alone. Their adjuvant activity exceeded that of aluminum hydroxide and approached that of Quillaja saponaria-derived saponin formulations. The nanocomplexes also induced balanced cellular immune responses comparable to those reported for Quil A-based nanosystems. These findings identify H. glabra as a promising alternative source of bioactive saponins and demonstrate the potential of plant-derived nanocomplexes as versatile adjuvant platforms for next-generation vaccines.